Education
About Us
Working with TipRanks
Follow Us
Orthofix International N.V. (OFIX)
NASDAQ:OFIX
OFIX Stock Chart & Stats
$15.49
-$0.08(-0.47%)
At close: 4:00 PM EST
$15.49
-$0.08(-0.47%)
Day’s Range― - ―
52-Week Range$10.24 - $20.48
Previous CloseN/A
Volume45.16K
Average Volume (3M)212.06K
Market Cap
$612.21M
Enterprise Value$720.71M
Total Cash (Recent Filing)$65.95M
Total Debt (Recent Filing)$204.48M
Price to Earnings (P/E)―
Beta1.21
Next Earnings
Mar 03, 2026EPS Estimate
-0.19Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.57
Shares Outstanding39,599,660
10 Day Avg. Volume220,565
30 Day Avg. Volume212,061
Financial Highlights & Ratios
PEG Ratio0.27
Price to Book (P/B)1.32
Price to Sales (P/S)0.83
P/FCF Ratio-73.28
Enterprise Value/Market Cap1.18
Enterprise Value/Revenue0.88
Enterprise Value/Gross Profit1.29
Enterprise Value/Ebitda136.91
Forecast
1Y Price Target
$21.33Price Target Upside37.70% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
EarningsAdjusted EPS result of $0.20 easily beat the estimate of $0.12.
Financial PerformanceRevenue of $205.6 million solidly beat the consensus estimate of $200.0 million.
Market PositionOrthofix believes it continues to capture market share in its bone growth therapies business and remains confident it can outperform industry growth rates.
Bears Say
Orthofix News
OFIX FAQ
What was Orthofix International N.V.’s price range in the past 12 months?
Orthofix International N.V. lowest stock price was $10.24 and its highest was $20.48 in the past 12 months.
What is Orthofix International N.V.’s market cap?
Orthofix International N.V.’s market cap is $612.21M.
When is Orthofix International N.V.’s upcoming earnings report date?
Orthofix International N.V.’s upcoming earnings report date is Mar 03, 2026 which is in 70 days.
How were Orthofix International N.V.’s earnings last quarter?
Orthofix International N.V. released its earnings results on Nov 04, 2025. The company reported -$0.57 earnings per share for the quarter, missing the consensus estimate of -$0.558 by -$0.012.
Is Orthofix International N.V. overvalued?
According to Wall Street analysts Orthofix International N.V.’s price is currently Undervalued.
Does Orthofix International N.V. pay dividends?
Orthofix International N.V. does not currently pay dividends.
What is Orthofix International N.V.’s EPS estimate?
Orthofix International N.V.’s EPS estimate is -0.19.
How many shares outstanding does Orthofix International N.V. have?
Orthofix International N.V. has 39,599,660 shares outstanding.
What happened to Orthofix International N.V.’s price movement after its last earnings report?
Orthofix International N.V. reported an EPS of -$0.57 in its last earnings report, missing expectations of -$0.558. Following the earnings report the stock price went down -7.41%.
Which hedge fund is a major shareholder of Orthofix International N.V.?
Currently, no hedge funds are holding shares in OFIX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Orthofix Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$21.33 (37.70% Upside)
$21.33 (37.70% Upside)
Blogger Sentiment
Neutral
OFIX Sentiment 50%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 66.6K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Positive
20 days / 200 days
Momentum
-11.13%
12-Months-Change
Fundamentals
Return on Equity
-24.60%
Trailing 12-Months
Asset Growth
-4.06%
Trailing 12-Months
Company Description
Orthofix International N.V.
Orthofix International N.V. is a global medical device company specializing in orthopedic and spine solutions. The company operates in two primary segments: Orthopedics and Spine. Orthofix is known for its innovative products, including bone growth stimulation devices, orthopedic implants, and spinal surgery solutions, aimed at improving patient outcomes in musculoskeletal treatments.
OFIX Company Deck
OFIX Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Orthofix demonstrated strong revenue growth and operational efficiency, with significant contributions from the U.S. Spine and Orthopedics segments. Despite challenges such as pricing pressure and product discontinuation, the company maintained positive cash flow and expanded EBITDA margins.View all OFIX earnings summariesOFIX Stock 12 Month Forecast
Average Price Target
$21.33
▲(37.70% Upside)
Technical Analysis
Ownership Overview
13.66% Insiders
13.07% Mutual Funds
49.46% Other Institutional Investors
11.08% Public Companies and
Individual Investors